News about

DCGI classifies 247 medical devices including PPEs, OT equipment and others

DCGI classifies 247 medical devices including PPEs, OT equipment and others

The Drug Controller General (India) has classified medical devices including personal protective equipment, devices in general hospitals and those pertaining to nephrology and renal care, pain management, operation theatre and certain softwares

| 20/09/2021 | By 678

Laurus Labs, Unitaid and CHAI ink agreement to accelerate development of HIV medication for children

Laurus Labs, Unitaid and CHAI ink agreement to accelerate development of HIV medication for children

Laurus Labs Limited, a leading research & development-driven and fully integrated pharmaceutical and biotech company in India, Unitaid and the Clinton Health Access Initiative (CHAI), announce agreement to accelerate the development, commercialization and registration of the bestin-class second- and third-line HIV treatment darunavir boosted

| 15/09/2021 | By 417

Moderna inks agreement with Resilience to manufacture mRNA for Covid-19 vaccine

Moderna inks agreement with Resilience to manufacture mRNA for Covid-19 vaccine

National Resilience, (Resilience), a company seeking to build the world's most advanced biopharmaceutical manufacturing ecosystem, and Moderna announced an agreement to manufacture drug substance for the Moderna Covid-19 vaccine

| 13/09/2021 | By 243

Indian API, CRAMS sectors to outperform other countries during 2021-26: research report

Indian API, CRAMS sectors to outperform other countries during 2021-26: research report

The Indian active pharmaceutical ingredients (API) sector is expected to outperform other countries with an estimated Compound Annual Growth Rate (CAGR) of 9.6 per cent over the calendar year 2021-26, while complex APIs would see a faster growth owing to the focus on complex formulations and others

| 13/09/2021 | By 359

Sandoz enters commercialization pact with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz enters commercialization pact with Bio-Thera Solutions for biosimilar bevacizumab

Sandoz, a Novartis division, announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706)

| 09/09/2021 | By 297

ABB drives enhance safety & energy efficiency at Bharat Biotech's Covaxin production unit with cleanroom infrastructure

ABB drives enhance safety & energy efficiency at Bharat Biotech's Covaxin production unit with cleanroom infrastructure

ABB drives play a key role in the cleanroom infrastructure of Bharat Biotech, India's first indigenous Covid-19 vaccine manufacturer. The inbuilt application functions of ABB's ACS560 drives help in maintaining the right environmental condition

| 08/09/2021 | By 654

Deal value in pharma industry decreases by 67.2 per cent in August: Globalata

Deal value in pharma industry decreases by 67.2 per cent in August: Globalata

The latest GlobalData report has revealed that the pharmaceutical industry reported 56 deals worth $11.7 billion last month as compared to the last 12-month average (August 2020 to July 2021) of 104 deals worth $28.9 billion

| 08/09/2021 | By 308

Panacea Biotec supplies maiden shipment of Sputnik V's second component produced in India

Panacea Biotec supplies maiden shipment of Sputnik V's second component produced in India

The Russian Direct Investment Fund (RDIF) and Panacea Biotec have announced the supply of the first shipment out of one million doses of the second component (human adenovirus serotype 5) of the Russian Sputnik V coronavirus vaccine manufactured by Panacea Biotec for sale in India, the company said in a statement

| 08/09/2021 | By 788

NeuExcell, Spark Therapeutics ink collaboration to develop novel gene therapy to treat Huntington's disease

NeuExcell, Spark Therapeutics ink collaboration to develop novel gene therapy to treat Huntington's disease

NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group, announced gene therapy collaboration aimed at developing a safe and effective treatment for patients suffering from Huntington's disease (HD)

| 08/09/2021 | By 428

SyntheticMR inks pact with Philips to include it's medical imaging solution in third party product catalogue

SyntheticMR inks pact with Philips to include it's medical imaging solution in third party product catalogue

SyntheticMR has entered an agreement with Philips to include SyntheticMR's medical imaging solution in their global product catalogue. The agreement means that SyntheticMR's solution SyMRI NEURO will be included in Philips' third-party product catalogue and enables Philips to offer the complete package to their customers

| 07/09/2021 | By 236

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members